Medical Research Stumbles over Globalization

Bio-ITworld.com: Clinical Trial Supply Chain Needs Improvement, 2008-Mar-5, by Ann Neuer

Overall, the study showed that just 13 percent of clinical trials products shipped to investigative sites are received on time and are 90 percent complete, showcasing the need for significant improvements in the supply chain process. These dismal results are not surprising to Kumar, who comments, “Most current supply chains are entirely inadequate for the realities of global trials today. Many pharmaceutical companies did invest in improving the supply chain when testing was easier, but many new testing locales have poor infrastructure, causing even more delays.”